Sydney, Australia (PRWEB) June 13, 2013

GenericsWeb, the leader in established pharmaceutical patent evaluation and browsing, recently published an article primarily based on its proprietary Pipeline Patent Intelligence that analyses possibilities in launching a generic Raloxifene solution for Eli Lillys blockbuster selective oestrogen receptor modulator (SERM) Evista